Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The World Parkinson Coalition has brought in eight new Science Ambassadors to increase outreach to researchers ahead of their next major Congress.

Dayne photographed in the lab next to a microscope

OPDC career development fellow Dr Dayne Beccano-Kelly has been selected by The World Parkinson Coalition (WPC) to be one of eight Science Ambassadors in the two years leading up to the 6th World Parkinson Congress in June 2022. The WPC Ambassadors will be promoting a premiere Parkinson’s learning experience for scientists, working to bring the Parkinson's community together to advance both the clinical and research goals of discovering new treatments.

Dr Beccano-Kelly has been a member of the Wade-Martins Group since 2015, where he has been utilising human iPSCs donated by people with Parkinson's (PwP) to create neurons for Parkinsonian models. Studying these models has enabled him to identify some of the earliest changes in Parkinson's in an effort to tackle the symptoms before they develop into the late stages.

On receiving his appointment, Dr Beccanno-Kelly said: "The WPC represents a powerful point of contact between medics, academic and PwPs. Bringing these individuals together allows the perspectives and ideas of each to be easily communicated to one another. Attending my first WPC in 2019, I was struck by how much these mix of viewpoints seemed to be influencing people's future plans; it was exciting to watch a novel way of pushing forwards towards better treatments. The WPC not only represents a triennial meeting, but also provides virtual panel led discussion groups and connections with the community (via online events such as choir groups) in the interim years. It is a tremendous meeting and one I will be strongly advocating healthcare professionals, PwPs and other scientists to attend!"

Read the appointment announcement on the WPC website.

Meet all eight WPC 2022 Science Ambassadors on the 6th World Parkinson Congress website.

Similar stories

Oxford Parkinson’s Disease Centre host the 2022 Oxford Parkinson’s Research Day

On Tuesday 29th November 2022, Professor Richard Wade-Martins and Professor Michele Hu from the Oxford Parkinson’s Disease Centre (OPDC) hosted the Oxford Parkinson’s Research Day at the Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford.

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Jaideep Pandit honoured with RCoA Gold Medal

Congratulations are in order for Professor Jaideep Pandit, Professor of Anaesthesia and consultant anaesthetist, who has received the rarely awarded prestigious Gold Medal of the Royal College of Anaesthetists. Professor Pandit was a student and research fellow at DPAG and is now an Academic Visitor in the department; he is also a Fellow and Tutor in Medicine at St John's College.

Louisa Zolkiewski awarded the Bruce Cattanach Prize 2022

Congratulations are in order for Louisa Zolkiewski, who completed her DPhil studies this year, on being awarded the 2022 Bruce Cattanach Prize by the Genetics Society for her DPhil thesis.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.